期刊
JOURNAL OF LEUKOCYTE BIOLOGY
卷 108, 期 1, 页码 73-81出版社
OXFORD UNIV PRESS
DOI: 10.1002/JLB.2MR0120-352RR
关键词
AK002; antolimab; eosinophils; ligands; mast cells; Siglec; signaling
资金
- National Institute of Allergy and Infectious Diseases [U19AI136443, U19AI070535, 107905120]
Mast cells and eosinophils are innate immune cells involved in both acute and chronic inflammatory responses. Siglecs are a family of cell surface receptors that share sialic acid binding activity. Over the past 20 years, our knowledge of the expression and function of Siglecs on cells of the immune system and others has greatly expanded, as has our understanding of their signaling, ligands, and possible roles in disease pathophysiology. Because of this, Siglecs have garnered interest as potential drug targets using strategies ranging from biologics to ligand-directed nanoparticles. This mini-review will highlight the state of our knowledge regarding human eosinophil and mast cell Siglecs, their biology, what they recognize, tools developed for in vitro and preclinical experimentation, and the status of ongoing efforts to develop drugs that engage eosinophil and mast cell Siglecs for potential therapeutic benefit.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据